Picture of Medacta SA logo

MOVE — Medacta SA News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareBalancedMid CapFalling Star

Medacta: Growth at a reasonable price - CS ups to "outperform"

** Credit Suisse upgrades Swiss medical device firm Medacta
 MOVE.S  to "outperform" from "neutral", citing growth at a
reasonable price
    ** The broker says that given its confidence in superior
medium-term growth, the industry-low levels at which Medacta is
currently trading offer an entry point
    ** Credit Suisse says the company is exposed to attractive
end markets and differentiates itself from competitors by
promoting innovative surgical approaches
    ** The brokerage sees the company's new products and U.S.
exposure as incremental growth drivers 
    ** It says it concludes that recent slower growth is "likely
temporary"

 ((marta.frackowiak@thomsonreuters.com))

Recent news on Medacta SA

See all news